FDA votes to bring the first synthetic cartilage product to the US

FDA ORTHO PANEL TO VOTE ON CARTIVA SYNTHETIC CARTILAGE IMPLANT (Orthopedics This Week)
Cartiva website
The FDA's Orthopaedic and Rehabilitation Devices Panel will meet on April 20, 2016 to discuss, make recommendations, and vote on the premarket approval application (PMA) for the Cartiva Synthetic Cartilage Implant (SCI), sponsored by Cartiva, Inc.
Cartiva's implant is an organic polymer-based biomaterial to mimic biologic cartilage. The device, according to an FDA announcement, is to be indicated for treatment of degenerative and post-traumatic arthritis in the first metatarsophalangeal joint...